Pfizer Says Its COVID Pill Used in Tandem with HIV Drug Cuts Risk of Hospitalization or Death by 89% in High-Risk Adults Who Have Been Exposed to Virus
- Pfizer said its Covid-19 pill, used with an HIV drug, cut the risk of hospitalization or death by 89% in high-risk adults who’ve been exposed to the virus.
- It’s now the second antiviral pill behind Merck’s to demonstrate strong effectiveness for treating Covid at the first sign of illness.
- Pfizer said it plans to submit its data to the Food and Drug Administration “as soon as possible.”